• Revenue up 31.9% to $213.0M
• Profit after tax up 39.2% to $115.2M
• Underlying EBIT up 40.5% to $157.7M
• Signed seven new contracts worth $520M and renewed two large contracts worth $130M

Pro Medicus Ltd reported its FY2025 results, which were the most successful year in the company's history. Revenue increased by 31.9% to $213.0M, profit after tax grew by 39.2% to $115.2M, and underlying EBIT rose by 40.5% to $157.7M. The company signed seven new contracts totaling $520M and renewed two large contracts worth $130M. Pro Medicus also completed seven cloud-based implementations, signed a research collaboration agreement with UCSF, and made significant progress with other 'ologies' and AI. The company's operational model, which is based on transaction minimums, has forward revenue of over $948M over the next five years. Pro Medicus continues to increase its footprint in the IDN (Integrated Delivery Network) space, with all recent IDN opportunities being cloud-deployed. The company also had a 100% renewal rate on its contracts, with all renewals at higher price points than the original contracts. Pro Medicus has also made advancements in its Visage 7 product line, including the Visage 7 Open Archive, Visage 7 Workflow, and Visage 7 CloudPACS, as well as expanding into new areas like Cardiology and Digital Pathology. The company's investment in AI research and development, including collaborations with UCSF and partnerships with Elucid and 4DX, positions it well to leverage AI as it becomes more mainstream.

Pro Medicus expects revenue, profit, and margins to continue growing strongly in FY2026 and beyond, based on its record FY2025 results and strong forward revenue pipeline.

Pro Medicus is well-positioned for continued growth, with a robust pipeline of new business opportunities, successful cloud-based implementations, and advancements in its product portfolio, including Visage 7 Open Archive, Visage 7 Workflow, and Visage 7 CloudPACS. The company's investment in AI research and development, as well as its strategic partnership with Apple for the Visage Ease VP on the Vision Pro platform, provide additional growth opportunities.